Medical News, Neuroscience, Pharmaceuticals, Women's health
FDA approves first dual-treatment migraine medication, ‘paradigm shift’ in migraine management

According to the company, taking the medication every other day for a week decreased migraine days by 30%, and nearly half of the participants reported a 50% reduction in moderate-to-severe

Economics, Medical News, Pharmaceuticals, World health
Recent studies provide new evidence to battle drug price increases

All three of the standard-of-care (SOC) medications analyzed by the researchers saw at least an 8 percent decrease in administration of the medication after price hikes. Two of the SOC

Biotechnology, Cancer, Medical News, Pharmaceuticals, Women's health
Promising ovarian cancer treatment proves effective and efficient

Preclinical trials of a new radiopharmaceutical for the treatment of ovarian cancer have shown promising results, with tumor growth and mass significantly reduced after use. The new radiopharmaceutical, which is

Cancer, Featured, Mood disorders, Pharmaceuticals
Drug commonly used as antidepressant has been found to help fight cancer

Monoamine oxidase inhibitors are a type of medicine used to treat depression. They operate by increasing levels of serotonin, the brain’s “happy hormone.” According to a recent UCLA study, such

Alzheimer's disease, Medical News, Neurocognitive disorders, Neuroscience, Pharmaceuticals, World health
FDA may approve first novel Alzheimer’s drug in 20 years

The Food and Drug Administration is about to make one of its most divisive rulings in years, deciding on the destiny of an Alzheimer’s drug that might be the first

Medical News, Metabolic syndrome, Obesity, Pharmaceuticals
FDA approves obesity drug that helped people cut weight 15%

On Friday, regulators announced that a new version of a popular diabetes medicine would be sold in the United States as a weight-loss treatment. Wegovy, a higher-dose variant of Novo